júní 2026) - Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag að félagið efni til sölutryggðs hlutafjárútboðs í Bandar…
Early mechanistic data positions ETHY-001 as a differentiated candidate in thyroid-eye disease, a space drawing growing…
The shift signals broader biotech convergence, but functional food and nutraceutical formulators should watch how AI-gu…
Antibody-drug conjugate expansion signals broader targeted-delivery innovation that nutraceutical formulators are watch…
Wildfire particulate exposure is emerging as a functional-foods category trigger, with brands eyeing lung-support and a…
Merzenich's neuroplasticity framework is foundational to the fast-growing cognitive supplement and digital therapeutics…
As protein-forward product development accelerates, consumer preference data points to meat quality as a pivotal lever …
The Tyson Foods-owned brand targets the premiumization trend in processed meats, though functional or fortified claims …
The clinical-stage biotech's tablet-based delivery approach draws attention as mucosal immunization research intersects…
Originally developed for vaccine biologics, the C1 platform's high-yield fermentation economics are attracting finished…
The coalition push highlights growing intersections between blood health, iron status nutrition, and functional supplem…
Pyruvate kinase activation as a therapeutic mechanism draws renewed attention as clinical-stage data surfaces at a majo…
